BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11221126)

  • 1. Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease.
    Green AJ; Giovannoni G; Hall-Craggs MA; Thompson EJ; Miller RF
    Sex Transm Infect; 2000 Dec; 76(6):443-6. PubMed ID: 11221126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid ferritin in HIV infected patients with acute neurological episodes.
    Deisenhammer F; Miller RF; Brink NS; Harrison MJ; Thompson EJ
    Genitourin Med; 1997 Jun; 73(3):181-3. PubMed ID: 9306897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
    Liuzzi GM; Mastroianni CM; Santacroce MP; Fanelli M; D'Agostino C; Vullo V; Riccio P
    J Neurovirol; 2000 Apr; 6(2):156-63. PubMed ID: 10822329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans. HIV Neurobehavioral Research Center Group (HNRC).
    Ellis RJ; Seubert P; Motter R; Galasko D; Deutsch R; Heaton RK; Heyes MP; McCutchan JA; Atkinson JH; Grant I
    Neurosci Lett; 1998 Sep; 254(1):1-4. PubMed ID: 9780077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cerebrospinal fluid protein tau concentration in neuro-AIDS.
    Andersson L; Blennow K; Fuchs D; Svennerholm B; Gisslén M
    J Neurol Sci; 1999 Dec; 171(2):92-6. PubMed ID: 10581374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus DNA in CSF from persons infected with HIV who had neurological disease.
    Brink NS; Sharvell Y; Howard MR; Fox JD; Harrison MJ; Miller RF
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):191-5. PubMed ID: 9703169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid concentration of fibronectin in patients with HIV-1 infection and central nervous system disorders.
    Torre D; Zeroli C; Ferrario G; Bonetta G; Fiori GP; Martegani R
    J Clin Pathol; 1993 Nov; 46(11):1039-41. PubMed ID: 8254093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.
    Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CS; Davies NN; Price P; Brew BJ
    BMC Neurol; 2015 Apr; 15():51. PubMed ID: 25880550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau).
    Krut JJ; Price RW; Zetterberg H; Fuchs D; Hagberg L; Yilmaz A; Cinque P; Nilsson S; Gisslén M
    Virulence; 2017 Jul; 8(5):599-604. PubMed ID: 27435879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration.
    Steinbrink F; Evers S; Buerke B; Young P; Arendt G; Koutsilieri E; Reichelt D; Lohmann H; Husstedt IW;
    Eur J Neurol; 2013 Mar; 20(3):420-428. PubMed ID: 23095123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological complications in patients with HIV/AIDS.
    Bolokadze N; Gabunia P; Ezugbaia M; Gatserelia L; Khechiashvili G
    Georgian Med News; 2008 Dec; (165):34-8. PubMed ID: 19124914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system.
    Christo PP; Vilela Mde C; Bretas TL; Domingues RB; Greco DB; Livramento JA; Teixeira AL
    J Neurol Sci; 2009 Dec; 287(1-2):79-83. PubMed ID: 19782379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseases.
    Constantinescu R; Mahamud U; Constantinescu C; Eriksson B; Novakova L; Olsson B; Rosengren L; Blennow K; Axelsson M
    Acta Neurol Scand; 2019 Sep; 140(3):177-183. PubMed ID: 31087810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection.
    Brew BJ; Bhalla RB; Paul M; Gallardo H; McArthur JC; Schwartz MK; Price RW
    Ann Neurol; 1990 Oct; 28(4):556-60. PubMed ID: 2252366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms.
    Kugathasan R; Collier DA; Haddow LJ; El Bouzidi K; Edwards SG; Cartledge JD; Miller RF; Gupta RK
    Clin Infect Dis; 2017 Apr; 64(8):1059-1065. PubMed ID: 28329096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid biomarkers in patients with central nervous system infections: a retrospective study.
    Di Stefano A; Alcantarini C; Atzori C; Lipani F; Imperiale D; Burdino E; Audagnotto S; Mighetto L; Milia MG; Di Perri G; Calcagno A
    CNS Spectr; 2020 Jun; 25(3):402-408. PubMed ID: 31130152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.
    Andreasen N; Vanmechelen E; Van de Voorde A; Davidsson P; Hesse C; Tarvonen S; Räihä I; Sourander L; Winblad B; Blennow K
    J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):298-305. PubMed ID: 9527138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.
    Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A
    J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
    Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
    J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.